Filing Details

Accession Number:
0001181431-13-060669
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-26 12:47:17
Reporting Period:
2013-11-26
Filing Date:
2013-11-26
Accepted Time:
2013-11-26 12:47:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
821995 Columbia Laboratories Inc CBRX Pharmaceutical Preparations (2834) 592758596
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567657 Brian Jonathan Jones Lloyd C/O Columbia Laboratories
4 Liberty Square
Boston MA 02110
Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Cbrx Stock On Open Market Acquisiton 2013-11-26 1,580 $6.32 2,580 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $6.30 to $6.33. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.